Search Results - "Salenius, Sharon"

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction by Nguyen, Paul L., M.D, Chen, Ming-Hui, Ph.D, Beckman, Joshua A., M.D., M.S, Beard, Clair J., M.D, Martin, Neil E., M.D., M.P.H, Choueiri, Toni K., M.D, Hu, Jim C., M.D., M.P.H, Hoffman, Karen E., M.D., M.P.H., M.H.Sc, Dosoretz, Daniel E., M.D, Moran, Brian J., M.D, Salenius, Sharon A., M.P.H, Braccioforte, Michelle H, Kantoff, Philip W., M.D, D’Amico, Anthony V., M.D., Ph.D, Ennis, Ronald D., M.D

“…Purpose It is unknown whether the excess risk of all-cause mortality (ACM) observed when androgen deprivation therapy (ADT) is added to radiation for men with…”
Get full text

Androgen Deprivation Therapy Use in the Setting of High-Dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality by Rose, Brent S., M.D, Chen, Ming-Hui, Ph.D, Wu, Jing, B.S, Braccioforte, Michelle H., M.P.H, Moran, Brian J., M.D, Doseretz, Daniel E., M.D, Katin, Michael J., M.D, Ross, Rudolf H., B.A, Salenius, Sharon A., M.A, D’Amico, Anthony V., M.D. Ph.D

“…Abstract Purpose The addition of androgen deprivation therapy (ADT) to radiation therapy (RT) is standard of care for men with intermediate and high-risk…”
Get full text

Radical prostatectomy vs radiation therapy and androgen‐suppression therapy in high‐risk prostate cancer by Westover, Kenneth, Chen, Ming‐Hui, Moul, Judd, Robertson, Cary, Polascik, Thomas, Dosoretz, Daniel, Katin, Michael, Salenius, Sharon, D'Amico, Anthony V.

“…Study Type – Therapy (retrospective cohort analysis) Level of Evidence 2b What's known on the subject? and What does the study add? Prostate cancer is…”
Get full text

Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease by D'AMICO, Anthony V, MORAN, Brian J, BRACCIOFORTE, Michelle H, DOSORETZ, Daniel, SALENIUS, Sharon, KATIN, Michael, ROSS, Rudi, CHEN, Ming-Hui

“…We estimated the risk of prostate cancer (PC) -specific mortality (PCSM) after brachytherapy alone or in conjunction with androgen suppression therapy (AST),…”
Get full text

The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection by Wattson, Daniel A., M.D, Chen, Ming-Hui, Ph.D, Moul, Judd W., M.D, Moran, Brian J., M.D, Dosoretz, Daniel E., M.D, Robertson, Cary N., M.D, Polascik, Thomas J., M.D, Braccioforte, Michelle H., B.S, Salenius, Sharon A., M.P.H, D’Amico, Anthony V., M.D., Ph.D

“…Purpose To determine whether an increasing number of high-risk factors is associated with higher prostate cancer–specific mortality (PCSM) among men treated…”
Get full text

Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer by Kang, Josephine, M.D., Ph.D, Chen, Ming-Hui, Ph.D, Zhang, Yuanye, M.S, Moran, Brian J., M.D, Dosoretz, Daniel E., M.D, Katin, Michael J., M.D, Braccioforte, Michelle H., B.S, Salenius, Sharon A., M.P.H, D'Amico, Anthony V., M.D., Ph.D

“…Purpose It has been recently shown that diabetes mellitus (DM) is significantly associated with the likelihood of presenting with high-grade prostate cancer…”
Get full text

Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy by Mitin, Timur, Chen, Ming-Hui, Zhang, Yuanye, Moran, Brian J, Dosoretz, Daniel E, Katin, Michael J, Braccioforte, Michelle H, Salenius, Sharon A, D'Amico, Anthony V

“…Black men present more frequently with high grade prostate cancer and are more likely to have diabetes mellitus. We evaluated whether there is an independent…”
Get more information

Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate by Winkfield, Karen M., M.D., Ph.D, Chen, Ming-Hui, Ph.D, Dosoretz, Daniel E., M.D, Salenius, Sharon A., M.P.H, Katin, Michael, M.D, Ross, Rudi, B.S, D’Amico, Anthony V., M.D., Ph.D

“…Purpose We investigated whether race was associated with risk of death following brachytherapy-based treatment for localized prostate cancer, adjusting for…”
Get full text

Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation by Nguyen, Paul L., Chen, Ming H., Goldhaber, Samuel Z., Martin, Neil E., Beard, Clair J., Dosoretz, Daniel E., Katin, Michael J., Ross, Rudi, Salenius, Sharon A., D'Amico, Anthony V

“…BACKGROUND: A study was undertaken to determine the impact of prior coronary revascularization (angioplasty, stent, or coronary artery bypass graft) on the…”
Get full text

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk by Braunstein, Lior Z, Chen, Ming-Hui, Dosoretz, Daniel E, Salenius, Sharon A, Katin, Michael J, Nanda, Akash, D'Amico, Anthony V

“…Micro-Abstract Whole-pelvis radiotherapy or a short-course (approximately 4 months) of androgen deprivation therapy yield an all-cause mortality benefit among…”
Get full text

Risk of All-Cause and Prostate Cancer–Specific Mortality After Brachytherapy in Men With Small Prostate Size by Nguyen, Paul L., M.D, Chen, Ming H., Ph.D, Choueiri, Toni K., M.D, Hoffman, Karen E., M.D., M.H.Sc., M.P.H, Hu, Jim C., M.D., M.P.H, Martin, Neil E., M.D., M.P.H, Beard, Clair J., M.D, Dosoretz, Daniel E., M.D, Moran, Brian J., M.D, Katin, Michael J., M.D, Braccioforte, Michelle H., B.S, Ross, Rudi, B.S, Salenius, Sharon A., M.P.H, Kantoff, Philip W., M.D, D'Amico, Anthony V., M.D., Ph.D

“…Background Brachytherapy for prostate cancer can be technically challenging in men with small prostates (≤20 cc), but it is unknown whether their outcomes are…”
Get full text

Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy by Dosoretz, Amy M., Chen, Ming‐Hui, Salenius, Sharon A., Ross, Rudolf H., Dosoretz, Daniel E., Katin, Michael J., Mantz, Constantine, Nakfoor, Bruce M., D'Amico, Anthony V.

“…BACKGROUND: Discrepancies exist regarding the impact of neoadjuvant hormone therapy (NHT) on the risk of all‐cause mortality (ACM) in men who receive…”
Get full text

Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy by Nanda, Akash, M.D., Ph.D, Chen, Ming-Hui, Ph.D, Moran, Brian J., M.D, Braccioforte, Michelle H., B.S, Dosoretz, Daniel, M.D, Salenius, Sharon, M.P.H, Katin, Michael, M.D, Ross, Rudi, B.S, D'Amico, Anthony V., M.D., Ph.D

“…Purpose To identify clinical factors associated with prostate cancer–specific mortality (PCSM), adjusting for comorbidity, in elderly men with…”
Get full text

Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy by Nanda, Akash, M.D., Ph.D, Chen, Ming-Hui, Ph.D, Moran, Brian J., M.D, Braccioforte, Michelle H., B.S, Dosoretz, Daniel, M.D, Salenius, Sharon, M.P.H, Katin, Michael, M.D, Ross, Rudi, B.S, D'Amico, Anthony V., M.D., Ph.D

“…Purpose To assess whether short-course total androgen blockade vs. a luteinizing hormone–releasing hormone (LHRH) agonist alone affects the risk of prostate…”
Get full text

A Survey of Clinical Research Coordinators in the Cooperative Group Setting of the American College of Radiology Imaging Network (ACRIN) by Smith, Wendy, BS, RTRCV, CCRP, Salenius, Sharon, MPH, Cobb, Cynthia, BS, RTRCT, CCRP, Marzan, Roslynn, BS, Sabina, Sophia, MBA, Beccaria, Lorna, BSN, CCRC, Sitton-Petro, Tracy, AAS, CTR, CCRP, Werner, D. Lynn, RN, CCRP, Kamm, Monene, AS, CRC, Lenz, Suzanne, MA, CCRP, Taylor, Tina

“…Rationale and Objectives As one of the newest cooperative groups funded by the National Cancer Institute in 1999, the American College of Radiology Imaging…”
Get full text

A Markov Chain Monte Carlo (MCMC) Multivariate Analysis of the Association of Vital Parameter Variation With the Lunar Cycle in Patients Hospitalized With COVID-19 by Koya, Supriya, Ponnam, Sreeja, Salenius, Sharon, Pamidighantam, Sayanu

“…Over the last three years, the world has been battling a long-drawn pandemic resulting from the coronavirus outbreak. Despite the safety measures, there have…”
Get full text

Information Needs Expressed During Patient-Oriented Oncology Consultations: Quantity, Variation, and Barriers by Ahamad, Anesa, Wallner, Paul, Salenius, Sharon, Ross, Rudi, Fernandez, Eduardo

“…High-quality oncology consultation includes patient-oriented communication tailored to patients’ individualized needs. Common methods used in studies to…”
Get full text

Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication by Dosoretz, D E, Galmarini, D, Rubenstein, J H, Katin, M J, Blitzer, P H, Salenius, S A, Dosani, R A, Rashid, M, Mestas, G, Hannan, S E

“…For patients who are medically unable to tolerate a surgical resection for technically resectable non-small-cell lung carcinoma, radiation therapy is an…”
Get more information

Patients treated with bladder preserving trimodality chemoradiation therapy (BPTMCRT) off-trial compared to those on trials by Ahamad, Anesa Waheda, Martinez, Alvaro, Salenius, Sharon, Ross, Rudi, Fernandez, Eduardo

“…Abstract only e16014 Background: We assessed characteristics and outcome of patients treated with radiotherapy for muscle-invasive bladder cancer off-trial at…”
Get full text

What do patients really want to know? by Ahamad, Anesa Waheda, Wallner, Paul E., Salenius, Sharon, Ross, Rudi, Fernandez, Eduardo

“…Abstract only e18261 Background: We describe and analyze the quantity, nature and spectrum of questions asked by patients at consultation for radiotherapy to…”
Get full text